Skip to content

Clinical research on the prevention and treatment of asymptomatic infection with COVID-19 by using Qingfei Paidu Granules combined with traditional Chinese medicine non-drug therapy based on the theory of preventing disease from exacerbating

Clinical research on the prevention and treatment of asymptomatic infection with COVID-19 by using Qingfei Paidu Granules combined with traditional Chinese medicine non-drug therapy based on the theory of preventing disease from exacerbating

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200059007
Enrollment
Unknown
Registered
2022-04-22
Start date
2022-04-20
Completion date
Unknown
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Group 1:Qingfei Paidu Granules Traditional Chinese Medicine and TCM Non-drugTherapy
Group 2:Qingfei Paidu Granules Traditional Chinese Medicine
Group 3:TCM Non-drugTherapy

Sponsors

Shanghai Municipal Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Asymptomatic infection with COVID-19; 2. Aged over 18 years; gender is not limited; 3. Within 48 hours of the first COVID-19 nucleic acid positive; 4. The informed consent process complies with the regulations, and the informed consent form is signed.

Exclusion criteria

Exclusion criteria: 1. Used drugs for the treatment of COVID-19, or similar traditional Chinese medicine, Chinese patent medicine, or non-drug therapy intervention of traditional Chinese medicine before enrollment; 2. Allergic constitution, such as allergic history of two or more drugs or food, or known allergy to the ingredients of this drug; 3. The researchers consider it inappropriate to participate in this study.

Design outcomes

Primary

MeasureTime frame
Time of first turning negative;

Secondary

MeasureTime frame
The hospitalization time;Conversion rate for mild or common cases;Relapse rate;

Countries

China

Contacts

Public ContactSun Yongning

Shanghai Municipal Hospital of Traditional Chinese Medicine

ynsun2002@126.com+86 18930177579

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026